These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30990265)

  • 1. [Involving patients in the evaluation of health technologies at the French National Authority for Health (HAS)].
    Nabarette H
    Sante Publique; 2018; 30(6):767-775. PubMed ID: 30990265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of the visibility of patient input in final recommendation documentation for three health technology assessment bodies.
    Wale JL; Sullivan M
    Int J Technol Assess Health Care; 2020 Jun; 36(3):197-203. PubMed ID: 32375904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES.
    Martelli N; Billaux M; Borget I; Pineau J; Prognon P; van den Brink H
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):12-8. PubMed ID: 25991072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening patient outcome evidence in health technology assessment: a coproduction approach.
    Rasburn M; Livingstone H; Scott SE
    Int J Technol Assess Health Care; 2021 Jan; 37():e12. PubMed ID: 33436125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scottish Health Technologies Group: enhancing patient engagement.
    Stewart JA; Clifton E; Macpherson K; Angelova N; Morrison G
    Int J Technol Assess Health Care; 2021 Jan; 37():e21. PubMed ID: 33468266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions.
    Wong CKH; Wu O; Cheung BMY
    Appl Health Econ Health Policy; 2018 Feb; 16(1):5-14. PubMed ID: 28702874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of patient involvement in a health technology assessment.
    Dipankui MT; Gagnon MP; Desmartis M; Légaré F; Piron F; Gagnon J; Rhiands M; Coulombe M
    Int J Technol Assess Health Care; 2015 Jan; 31(3):166-70. PubMed ID: 26062904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health technology assessment in Australia: a role for clinical registries?
    Scott AM
    Aust Health Rev; 2017 Mar; 41(1):19-25. PubMed ID: 27028134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FOR ACTION.
    Abelson J; Wagner F; DeJean D; Boesveld S; Gauvin FP; Bean S; Axler R; Petersen S; Baidoobonso S; Pron G; Giacomini M; Lavis J
    Int J Technol Assess Health Care; 2016 Jan; 32(4):256-264. PubMed ID: 27670693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAKEHOLDER INVOLVEMENT IN THE HEALTH TECHNOLOGY ASSESSMENT PROCESS IN LATIN AMERICA.
    Pichon-Riviere A; Soto N; Augustovski F; Sampietro-Colom L
    Int J Technol Assess Health Care; 2018 Jan; 34(3):248-253. PubMed ID: 29888698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT FOR THE ADOPTION OF INNOVATIVE MEDICAL DEVICES WITHIN FRENCH HOSPITALS: OPPORTUNITIES AND CHALLENGES FOR INDUSTRY.
    Dutot C; Mercier G; Borget I; de Sauvebeuf C; Martelli N
    Int J Technol Assess Health Care; 2017 Jan; 33(2):297-302. PubMed ID: 28578711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health technology assessment use and dissemination by patient and consumer groups: why and how?
    Fattal J; Lehoux P
    Int J Technol Assess Health Care; 2008; 24(4):473-80. PubMed ID: 18828943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating patient perspectives in health technology assessments and clinical practice guidelines.
    Hämeen-Anttila K; Komulainen J; Enlund H; Mäkelä M; Mäkinen E; Rannanheimo P; Sipilä R
    Res Social Adm Pharm; 2016; 12(6):903-913. PubMed ID: 26778190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality of health care, accreditation, and health technology assessment in Croatia: role of agency for quality and accreditation in health].
    Mittermayer R; Huić M; Mestrović J
    Acta Med Croatica; 2010 Dec; 64(5):425-34. PubMed ID: 21692267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Power relations and contrasting conceptions of evidence in patient-involvement processes used to inform health funding decisions in Australia.
    Lopes E; Carter D; Street J
    Soc Sci Med; 2015 Jun; 135():84-91. PubMed ID: 25950114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involving patients in health technology funding decisions: stakeholder perspectives on processes used in Australia.
    Lopes E; Street J; Carter D; Merlin T
    Health Expect; 2016 Apr; 19(2):331-44. PubMed ID: 25703958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six Sigma: not for the faint of heart.
    Benedetto AR
    Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction and uptake of new medical technologies in the Australian health care system: a qualitative study.
    Gallego G; Casey R; Norman R; Goodall S
    Health Policy; 2011 Oct; 102(2-3):152-8. PubMed ID: 21601934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.